Genpact (NYSE:G) Azioni

Genpact

Genpact Ltd is a provider of business process management services. Clients are industry verticals and operate in banking and financial services, insurance, capital markets, consumer product goods, life sciences, infrastructure, manufacturing and services, healthcare, and high-tech. Genpact's services include aftermarket, direct procurement, risk and compliance, human resources, IT, industrial solutions, collections, finance and accounting, and media services. Genpact's end market by revenue is India. It is a General Electric spin-off, which is still a large source of revenue for Genpact.

Genpact Ltd

Gravity - United States dollar

Cambria Global Asset Allocation ETF

Gabelli Equity Trust, Inc. (The) Common Stock

Gabelli Equity Trust Inc

GEORGIA BANCSHARES INC by Georgia Bancshares, Inc.

Georgia Bancshares Inc

German American Bancorp, Inc. - Common Stock

German American Bancorp Inc

Gabelli ETFs Trust Gabelli Financial Services Opportunities ETF

GRAND BANK CORPORATION by Grand Bank Corp.

Grand Bank Corp

Gaby Inc Ordinary Shares

Gabelli Equity Trust, Inc. (The) Series G Cumulative Preferred Stock

Gabelli Equity Trust, Inc. (The) Pfd Ser H

Gabelli Equity Trust, Inc. (The) 5.00% Series K Cumulative Preferred Stock

Green Automotive Co Corp

GACW Inc

GADSDEN PROPERTIES INC by Gadsden Properties Inc.

GULF ALTERNATIVE ENGY CRP by Gulf Alternative Energy Corp.

Simplify Exchange Traded Funds Simplify Gamma Emerging Market Bond ETF

GRUPO AEROPORTR CNTRO B by Grupo Aeroportuario del Centro Norte S.A.B. de C.V.

Grupo Aeroportuario del Centro Norte SAB de CV

GA eXpress Inc

GURU APP FACTORY CORP by GURU APP FACTORY CORP

GameFi

GREAT AMER FINCL CORP by Great American Financial Corp.

Great American Financial Corp

GLOBAL ARENA HLDG INC by Global Arena Holding, Inc.

Global Arena Holding Inc

Gaia Inc

GAIL INDIA LTD REG S/GDR by Gail India Ltd.

GAIL (India) Ltd

GAIL INDIA LTD S/ADR 144A by Gail India Ltd.

Gladstone Investment Corporation - Business Development Company

Gladstone Investment Corp

Gladstone Investment Corporation - 7.875% Notes due 2030

Gladstone Investment Corporation - 8.00% Notes due 2028

Gladstone Investment Corporation - 5.00% Notes Due 2026

Gladstone Investment Corporation - 4.875% Notes due 2028

SPDR SSgA Global Allocation ETF

Galxe - United States dollar

Gala Games - United States dollar

GALDERMA GROUP AG U/ADR by GALDERMA GROUP AG

Galderma Group AG

GALANTAS GOLD CORP by Galantas Gold Corp.

Galantas Gold Corp

Galileo Mining Ltd

Galenica Ltd

Galore Resources Inc

Galectin Therapeutics Inc. - Common Stock

Galectin Therapeutics Inc

General American Investors, Inc. Common Stock

General American Investors Co Inc

Gambling.com Group Limited - Ordinary Shares

Gambling.com Group Ltd

GAMMA COMMUNICATIONS PLC by GAMMA COMMUNICATIONS PLC

Gamma Communications PLC

GOLDEN ARROW MERGER CORP UNIT 1 CL A & 1/3 WT EXP

GameSquare Holdings Inc

GameCredits

Gamelancer Media Corp

GAMCO INVESTORS INC A by GAMCO Investors, Inc.

GAMCO Investors Inc

GREAT AMER FOOD CHAIN INC by Great American Food Chain, Inc. (The)

Great American Food Chain Inc

Amplify Video Game Leaders ETF

General American Investors Company, Inc. Cumulative Preferred Stock

GAN Ltd Ordinary Shares

Gander Gold Corp

GANDER GOLD CORP by Gander Gold Corporation

Gain Therapeutics Inc

Gap Inc

GOLDEN APPLE OIL&GAS INC by Golden Apple Oil & Gas, Inc.

Golden Apple Oil and Gas Inc

FT Vest U.S. Equity Moderate Buffer ETF - April

Generation Asia I Acquisition Ltd Ordinary Shares - Class A

Generation Asia I Acquisition Ltd

Generation Asia I Acquisition Ltd Units (1 Ord Class A & 1/2 War)

Generation Asia I Acquisition Ltd Warrants (01/01/9999)

GARB-OIL & POWER CORP by Garb Oil & Power Corp.

Garb Oil & Power Corp

Gari Network - United States dollar

Axcap Ventures Inc Class A

AXCAP VENTURES INC by Axcap Ventures Inc.

Axcap Ventures Inc

iShares MSCI USA Quality GARP ETF

GOLDEN AGRI-RES ORD by Golden Agri-Resources

Golden Agri-Resources Ltd

GOLDEN AGRI-RES UNSP/ADR by Golden Agri-Resources

GALLERY RES LTD by Gallery Resources Limited

Gallery Resources Ltd

GOLDEN ARROW RES CP NEW by Golden Arrow Resource Corp.

Golden Arrow Resources Corp

GASE Energy Inc

General Assembly Holdings Ltd Class A

NATURGY ENERGY GROUP S A by Naturgy Energy Group SA

Naturgy Energy Group SA

NATURGY ENERGY GRP U/ADR by Naturgy Energy Group SA

StealthGas Inc

Gabelli Automation ETF

NG ENERGY INTL CORP by NG Energy International Corp.

NG Energy International Corp

Marblegate Acquisition Corp

GATE

Marblegate Acquisition Corp Units (1 Ord Share Class A & 1/2 War)

Marblegate Acquisition Corp Warrants (31/08/2026)

GATOS SILVER INC COM

GATX Corp

Galiano Gold Inc

FT Vest U.S. Equity Moderate Buffer ETF - August

Gauzy Ltd

Gawk Inc

Galaxy Next Generation Inc

MONTAUK METALS INC by Montauk Metals Inc.

Montauk Metals Inc

Galway Metals Inc

Global Blue Group Holding AG Ordinary Shares

Global Blue Group Holding AG

Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust Common Shares of Beneficial Interest

Guggenheim Taxable Municipal Managed Duration Trust

GBA HLDGS LTD by GBA HLDGS LTD.

Deutsche Bank analyst Bryan Keane reinstates Genpact (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/G#NYSE">G</a>) with a Hold and announces $47 price target.

News

Price Target

Initiation

Analyst Ratings

Deutsche Bank Reinstates Hold on Genpact, Announces $47 Price Target

In the current session, the stock is trading at $45.61, after a 1.38% increase. Over the past month, Genpact Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/G#NYSE">G</a>) stock increased by 8.41%, and in the past year, by 46.99%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2025/1751554822_0.png" alt="Past Year Chart" />

<h3>Genpact P/E Compared to Competitors</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of the 31.28 in the Professional Services industry, Genpact Inc. has a lower P/E ratio of 15.3. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1751554822_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

P/E Ratio Insights for Genpact

Mizuho analyst Dan Dolev maintains Genpact (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/G#NYSE">G</a>) with a Neutral and raises the price target from $48 to $51.

Mizuho Maintains Neutral on Genpact, Raises Price Target to $51

Needham analyst Mayank Tandon reiterates Genpact (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/G#NYSE">G</a>) with a Buy and maintains $50 price target.

Reiteration

Needham Reiterates Buy on Genpact, Maintains $50 Price Target

Combination will fast-track Genpact's expansion of advanced technology solutions, amplifying data and AI capabilities, domain expertise, and strategic partnerships&nbsp;&nbsp;
NEW YORK, June 5, 2025 /PRNewswire/ --&nbsp;Genpact (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/G#NYSE">G</a>), a global advanced technology services and solutions company, today announced it has acquired XponentL Data, a data products and artificial intelligence (AI) solutions provider. XponentL brings differentiated domain-led data strategy, design, and engineering capabilities; deep industry experience; and strategic partnerships. This acquisition builds on Genpact's pivot to data, AI, and other advanced technologies, further enhancing Genpact's ability to help clients across the lifecycle of AI transformation, from strategy through implementation.

Genpact Acquires XponentL Data; Financial Details Of The Transaction Were Not Disclosed.

Genpact Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/G#NYSE">G</a>) reported better-than-expected earnings for the first quarter, but <a href="https://www.benzinga.com/quote/G/earnings">lowered its FY25 earnings outlook.</a>
The company posted quarterly earnings of 84 cents per share which beat the analyst consensus estimate of 79 cents per share. The company reported quarterly sales of $1.21 billion which met the analyst consensus estimate.
&#8220;We entered 2025 with strong momentum. Revenue in the first quarter grew 8% year-over-year with Data-Tech-AI revenue up 12%, on a constant currency basis, driving adjusted EPS growth of 16%. Looking ahead, our deep process and domain expertise remains a key competitive advantage as we partner with clients to optimize costs and accelerate transformation using AI and other advanced technologies,&#8221; said Balkrishan &#8220;BK&#8221; Kalra, Genpact&#8217;s President &amp; CEO. &#8220;Although the operating environment has changed since the beginning of the year, the strength of our business model and resilience of our strategy remain clear. We believe our continued focus on accelerating innovation, deepening client relationships, and driving results positions us to accelerate growth in the future.&#8221;
Genpact lowered its FY2025 GAAP EPS guidance from $3.04-$3.11 to $2.90-$3.01. The company also slashed its FY2025 adjusted EPS guidance from $3.52-$3.59 to $3.41-$3.52.
Genpact shares fell 0.3% to close at $49.55 on Wednesday.
These analysts made changes to their price targets on Genpact following earnings announcement.
<ul>
<li>Needham analyst Mayank Tandon maintained Genpact with a Buy and lowered the price target from $55 to $50.</li>
<li>Baird analyst David Koning maintained the stock with a Neutral and lowered the price target from $56 to $50.</li>
</ul>
Considering buying G stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="583" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08092459/image-85-1024x583.png" alt="" class="wp-image-908000" style="width:560px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08092459/image-85-1024x583.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08092459/image-85-300x171.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08092459/image-85-768x437.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08092459/image-85.png 1137w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45251088/top-3-financial-stocks-that-may-plunge-in-may">Top 3 Financial Stocks That May Plunge In May</a> </li>
</ul>
Photo via Shutterstock

Earnings

Trading Ideas

Genpact Analysts Cut Their Forecasts After Q1 Results

Baird analyst David Koning maintains Genpact (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/G#NYSE">G</a>) with a Neutral and lowers the price target from $56 to $50.

Baird Maintains Neutral on Genpact, Lowers Price Target to $50

U.S. stock futures were higher this morning, with the Nasdaq futures gaining over 1% on Thursday.
Shares of Arm Holdings PLC &#8211; ADR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) fell sharply in today's pre-market trading after the company reported fourth-quarter financial results and issued FY26 guidance below estimates. Also, the company issued first-quarter <a href="https://www.benzinga.com/quote/arm/earnings">adjusted EPS guidance below estimates.</a>
Arm Holdings reported quarterly earnings of 55 cents per share, which beat the analyst consensus estimate of 52 cents. Quarterly revenue came in at $1.24 billion, which beat the consensus estimate of $1.23 billion and is an increase over revenue of $928 million from the same period last year.
Arm Holdings shares tumbled 10.6% to $110.88 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>NetClass Technology Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTCL#NASDAQ">NTCL</a>) shares dipped 18.7% to $26.37 in pre-market trading.</li>
<li>Fluence Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNC#NASDAQ">FLNC</a>) shares fell 15.1% to $3.83 in pre-market trading after the company reported a wider-than-expected quarterly loss and lowered its FY25 sales forecast.</li>
<li>Semrush Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEMR#NYSE">SEMR</a>) declined 13% to $8.89 in pre-market trading after posting downbeat quarterly earnings.</li>
<li>Emerald Holding Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EEX#NYSE">EEX</a>) dipped 12.6% to $4.01 in today's pre-market trading. Emerald Holding recently reported better-than-expected first-quarter financial results and issued FY25 sales guidance with its midpoint above estimates.</li>
<li>Consensus Cloud Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCSI#NASDAQ">CCSI</a>) declined 10.2% to $20.03 in pre-market trading after reporting first-quarter results.</li>
<li>Genpact Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/G#NYSE">G</a>) shares tumbled 9.2% to $45.01 in pre-market trading after the company cut its FY25 forecast.</li>
<li>Equinox Gold Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQX#NYSE">EQX</a>) fell 8.9% to $6.22 in pre-market trading following weak quarterly results.</li>
<li>Fortinet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTNT#NASDAQ">FTNT</a>) dipped 8.6% to $97.55 in pre-market trading following first-quarter results.</li>
<li>Cleveland-Cliffs Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) dipped 7.6% to $7.84 in pre-market trading as the company posted a wider-than-expected loss for the first quarter after the closing bell on Wednesday. The company also said it expects full-year 2025 steel unit cost reductions of approximately $50 per net ton compared to the prior year. The company anticipates full-year capital expenditures of approximately $625 million, down from prior guidance of $700 million.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45251088/top-3-financial-stocks-that-may-plunge-in-may">Top 3 Financial Stocks That May Plunge In May</a> </li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

Movers

CCSI

FLNC

FTNT

NTCL

SEMR

Arm Holdings, Fluence Energy, Semrush And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Solidion Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STI#NASDAQ">STI</a>) shares moved upwards by 51.0% to $0.14 during Thursday's pre-market session. The market value of their outstanding shares is at $19.3 million. </li>
<li>LegalZoom.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LZ#NASDAQ">LZ</a>) stock increased by 17.24% to $8.5. The company's market cap stands at $1.5 billion. The company's, Q1 earnings came out yesterday. </li>
<li>ATIF Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBAI#NASDAQ">ZBAI</a>) stock moved upwards by 16.12% to $1.08. The company's market cap stands at $18.7 million. </li>
<li>Tutor Perini (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPC#NYSE">TPC</a>) shares moved upwards by 15.1% to $27.2. The market value of their outstanding shares is at $1.4 billion. As per the press release, Q1 earnings came out yesterday. </li>
<li>Sunrun (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) stock increased by 13.12% to $8.36. The company's market cap stands at $1.9 billion. The company's, Q1 earnings came out yesterday. </li>
<li>Montrose Environmental Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MEG#NYSE">MEG</a>) stock moved upwards by 12.49% to $16.93. The company's market cap stands at $586.8 million. The company's, Q1 earnings came out yesterday. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Energy Recovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERII#NASDAQ">ERII</a>) stock declined by 26.9% to $11.0 during Thursday's pre-market session. The company's market cap stands at $602.3 million. The company's, Q1 earnings came out yesterday. </li>
<li>Fluence Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNC#NASDAQ">FLNC</a>) shares decreased by 16.19% to $3.78. The company's market cap stands at $491.5 million. The company's, Q2 earnings came out yesterday. </li>
<li>Toppoint Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/TOPP#AMEX">TOPP</a>) stock fell 12.33% to $1.28. The market value of their outstanding shares is at $22.4 million. </li>
<li>Nocera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCRA#NASDAQ">NCRA</a>) stock fell 11.89% to $0.89. The market value of their outstanding shares is at $12.4 million. </li>
<li>Liquidity Services (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LQDT#NASDAQ">LQDT</a>) stock declined by 10.69% to $28.16. The company's market cap stands at $874.0 million. As per the news, the Q2 earnings report came out today. </li>
<li>Genpact (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/G#NYSE">G</a>) shares declined by 10.4% to $44.4. The company's market cap stands at $7.8 billion. As per the news, the Q1 earnings report came out yesterday. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ERII

LQDT

NCRA

TOPP

ZBAI

12 Industrials Stocks Moving In Thursday's Pre-Market Session

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Rosenblatt raised Coherent Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) price target from $80 to $95. Rosenblatt analyst Mike Genovese maintained a Buy rating. Coherent shares closed at $69.62 on Wednesday. See how other <a href="https://www.benzinga.com/quote/COHR/analyst-ratings">analysts view this stock</a>.</li>
<li>Chardan Capital boosted the price target for Seres Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCRB#NASDAQ">MCRB</a>) from $1.25 to $6. Chardan Capital analyst Keay Nakae downgraded the stock from Buy to Neutral. Seres Therapeutics shares closed at $8.29 on Wednesday. See how other analysts <a href="https://www.benzinga.com/quote/MCRB/analyst-ratings">view this stoc</a>k.</li>
<li>Needham cut Genpact Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/G#NYSE">G</a>) price target from $55 to $50. Needham analyst Mayank Tandon maintained a Buy rating. Genpact shares closed at $49.55 on Wednesday. See how other analysts <a href="https://www.benzinga.com/quote/G/analyst-ratings">view this stoc</a>k.</li>
<li>HC Wainwright &amp; Co. slashed the price target for Korro Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRRO#NASDAQ">KRRO</a>) from $115 to $100. HC Wainwright &amp; Co. analyst Mitchell Kapoor maintained a Buy rating. Korro Bio shares closed at $13.93 on Wednesday. <a href="https://www.benzinga.com/quote/KRRO/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Telsey Advisory Group slashed the price target for Holley Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLLY#NASDAQ">HLLY</a>) from $4.5 to $2.75. Telsey Advisory Group analyst Joseph Feldman maintained an Outperform rating. Holley shares closed at $1.77 on Wednesday. <a href="https://www.benzinga.com/quote/HLLY/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Piper Sandler increased Paycom Software, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAYC#NYSE">PAYC</a>) price target from $224 to $246. Piper Sandler analyst Arvind Ramnani maintained a Neutral rating. Paycom Software shares settled at $228.67 on Wednesday. <a href="https://www.benzinga.com/quote/payc/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Needham increased Uber Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) price target from $90 to $100. Needham analyst Bernie McTernan maintained a Buy rating. Uber shares closed at $83.65 on Wednesday. <a href="https://www.benzinga.com/quote/uber/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Jones Trading cut Greystone Housing Impact Investors LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GHI#NYSE">GHI</a>) price target from $15 to $3.5. Jones Trading analyst Jason Weaver maintained a Buy rating. Greystone Housing Impact Investors shares closed at $11.39 on Wednesday.  <a href="https://www.benzinga.com/quote/ghi/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Rosenblatt slashed the price target for Sonos, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONO#NASDAQ">SONO</a>) from $18 to $15. Rosenblatt analyst Steve Frankel maintained a Buy rating. Sonos shares settled at $8.97 on Wednesday. <a href="https://www.benzinga.com/quote/sono/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Needham cut Unity Software Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/U#NYSE">U</a>) price target from $33 to $30. Needham analyst Bernie McTernan maintained a Buy rating. Unity Software shares closed at $20.66 on Wednesday. <a href="https://www.benzinga.com/quote/u/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying UBER stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="560" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08080339/image-2-32-1024x560.png" alt="" class="wp-image-907776" style="width:667px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08080339/image-2-32-1024x560.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08080339/image-2-32-300x164.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08080339/image-2-32-768x420.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08080339/image-2-32.png 1151w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45251088/top-3-financial-stocks-that-may-plunge-in-may">Top 3 Financial Stocks That May Plunge In May</a> </li>
</ul>
Photo via Shutterstock

COHR

HLLY

KRRO

MCRB

PAYC

SONO

UBER

Uber To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Thursday

WIIM

Genpact shares are trading lower after the company reported Q1 financial results and cut its FY25 guidance below estimates. Also, the company issued Q2 adjusted EPS guidance with its midpoint below estimates.

Needham analyst Mayank Tandon maintains Genpact (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/G#NYSE">G</a>) with a Buy and lowers the price target from $55 to $50.

Needham Maintains Buy on Genpact, Lowers Price Target to $50

<h3>Gainers</h3>
<ul>
<li>NN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNBR#NASDAQ">NNBR</a>) stock increased by 26.2% to $2.31 during Wednesday's after-market session. The company's market cap stands at $115.3 million. As per the news, the Q1 earnings report came out today. </li>
<li>Tutor Perini (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPC#NYSE">TPC</a>) shares increased by 18.49% to $28.0. The company's market cap stands at $1.4 billion. As per the news, the Q1 earnings report came out today. </li>
<li>LegalZoom.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LZ#NASDAQ">LZ</a>) stock rose 11.57% to $8.1. The market value of their outstanding shares is at $1.4 billion. The company's, Q1 earnings came out today. </li>
<li>Solidion Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STI#NASDAQ">STI</a>) shares increased by 9.45% to $0.1. The market value of their outstanding shares is at $13.9 million. </li>
<li>Sunrun (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) shares increased by 9.06% to $8.06. The market value of their outstanding shares is at $1.8 billion. As per the press release, Q1 earnings came out today. </li>
<li>Energous (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WATT#NASDAQ">WATT</a>) stock rose 8.74% to $0.3. The company's market cap stands at $9.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Fluence Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNC#NASDAQ">FLNC</a>) stock declined by 15.1% to $3.83 during Wednesday's after-market session. The company's market cap stands at $498.0 million. As per the press release, Q2 earnings came out today. </li>
<li>Energy Recovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERII#NASDAQ">ERII</a>) stock fell 13.9% to $12.95. The company's market cap stands at $709.0 million. The company's, Q1 earnings came out today. </li>
<li>Genpact (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/G#NYSE">G</a>) shares decreased by 13.1% to $43.06. The company's market cap stands at $7.5 billion. As per the press release, Q1 earnings came out today. </li>
<li>Micropolis Hldgs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MCRP#AMEX">MCRP</a>) shares fell 10.1% to $2.85. The market value of their outstanding shares is at $96.5 million. </li>
<li>Toppoint Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/TOPP#AMEX">TOPP</a>) stock fell 8.81% to $1.33. The market value of their outstanding shares is at $23.2 million. </li>
<li>AerSale (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASLE#NASDAQ">ASLE</a>) stock declined by 7.67% to $6.5. The company's market cap stands at $304.5 million. The company's, Q1 earnings came out today. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ASLE

MCRP

NNBR

WATT

12 Industrials Stocks Moving In Wednesday's After-Market Session

<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="5" rowspan="1">
(Per share data)
&nbsp;
</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="3" rowspan="1">Quarter ending June 30, 2025</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">Lower</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">Upper</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Diluted EPS</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.72</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.73</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Estimated stock-based compensation expense</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">0.13</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">0.13</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Estimated amortization and impairment of acquired intangible assets</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">0.02</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">0.02</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Estimated tax impact on stock-based compensation expense</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">(0.02)</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">(0.02)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Estimated tax impact on amortization and impairment of acquired intangible assets</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">(0.01)</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">(0.01)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted diluted EPS</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.84</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.86</td>
</tr>
</tbody>
</table>
</figure><figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">____________________________</td>
</tr>
</tbody>
</table>
</figure>

Guidance

Genpact Sees Q2 Adj EPS $0.84-$0.86 vs $0.86 Est

<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="5" rowspan="1">
Reconciliation of Outlook for Diluted EPS to Adjusted Diluted EPS7
(Per share data)
&nbsp;
</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="3" rowspan="1">Year ending December 31, 2025</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">Lower</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">Upper</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Diluted EPS</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.90</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3.01</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Estimated stock-based compensation expense</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">0.54</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">0.54</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Estimated amortization and impairment of acquired intangible assets</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">0.09</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">0.09</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Estimated tax impact on stock-based compensation expense</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">(0.10)</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">(0.10)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Estimated tax impact on amortization and impairment of acquired intangible assets</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">(0.02)</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">(0.02)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted diluted EPS</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3.41</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3.52</td>
</tr>
</tbody>
</table>
</figure>
The following tables show the reconciliation of forward-looking non-GAAP financial measures to the most directly comparable GAAP measures for the

Genpact Lowers FY2025 Adj EPS Guidance from $3.52-$3.59 to $3.41-$3.52 vs $3.54 Est

Genpact Lowers FY2025 GAAP EPS Guidance from $3.04-$3.11 to $2.90-$3.01 vs $3.09 Est

Genpact (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/G#NYSE">G</a>) reported quarterly earnings of $0.84 per share which beat the analyst consensus estimate of $0.79 by 6.33 percent. This is a 15.07 percent increase over earnings of $0.73 per share from the same period last year. The company reported quarterly sales of $1.21 billion which met the analyst consensus estimate. This is a 7.32 percent increase over sales of $1.13 billion the same period last year.

Comments

Genpact

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO